default author photo

Hirokazu Taniguchi

Nagasaki University

SCHOLARLY PAPERS

6

DOWNLOADS

202

TOTAL CITATIONS

0

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Genomic Landscape of Pleural Mesothelioma in Japanese Patients: A Comprehensive Analysis Using Nationwide Database

Downloads 55 (1,010,164)

Genomic Landscape of Pleural Mesothelioma in Japanese Patients: A Comprehensive Analysis Using Nationwide Database

Number of pages: 25 Posted: 02 Dec 2025
Hirokazu Taniguchi, Kazumasa Akagi, Takahito Fukuda, Takuya Honda, Hirokazu Kurohama, Nozomi Ueki, Yuki Matsuoka, Emiko Udo, Saya Yahata, Shoko Miura, Hiromi Tomono, Noritaka Honda, Yosuke Dotsu, Midori Matsuo, Shinnosuke Takemoto, Izumi Sato, Shinji Okano, Masahiro Nakashima, Hiroshi Mukae and Kazuto Ashizawa
Nagasaki University, National Cancer Center Research Institute, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University - Department of Respiratory Medicine and Nagasaki University - Nagasaki University Hospital
Downloads 38 (1,238,337)

Abstract:

Loading...

Mesothelioma, comprehensive cancer genomic profiling, gene alterations, database analysis, cancer genomic medicine

Genomic Landscape of Pleural Mesothelioma in Japanese Patients: A Comprehensive Analysis Using Nationwide Database

Number of pages: 27 Posted: 12 Feb 2026
Hirokazu Taniguchi, Kazumasa Akagi, Takahito Fukuda, Takuya Honda, Hirokazu Kurohama, Nozomi Ueki, Yuki Matsuoka, Emiko Udo, Shoko Miura, Shinnosuke Takemoto, Saya Yahata, Midori Matsuo, Yosuke Dotsu, Hiromi Tomono, Noritaka Honda, Izumi Sato, Shinji Okano, Masahiro Nakashima, Hiroshi Mukae and Kazuto Ashizawa
Nagasaki University, National Cancer Center Research Institute, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University, Nagasaki University - Department of Respiratory Medicine and Nagasaki University - Nagasaki University Hospital
Downloads 17 (1,537,408)

Abstract:

Loading...

Mesothelioma, comprehensive cancer genomic profiling, gene alterations, database analysis, cancer genomic medicine

2.

Biological Impact of Chemotherapy During Treatment with Egfr Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer Positive for Egfr Activating Mutations

Number of pages: 24 Posted: 11 Apr 2025
Eiji Iwama, Kazuko Sakai, Taishi Harada, Shintaro Kanda, Shunichi Sugawara, Toshihide Yokoyama, Hirokazu Taniguchi, Kaoru Tanaka, Ryo Toyozawa, Kenichi Koyama, Yoshitaka Zenke, Gen Kida, Yasuhiko Nishioka, Hiroshi Yokouchi, Masayuki Hirose, Kazuto Nishio, Nobuyuki Yamamoto, Yuichiro Ohe and Isamu Okamoto
Kyushu University - Kyushu University Hospital, Kindai University - Kindai University Hospital, affiliation not provided to SSRN, Shinshu University - Department of Hematology and Medical Oncology, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kurashiki Central Hospital - Department of Respiratory Medicine, Nagasaki University, Kindai University, National Hospital Organization Kyushu Cancer Center, Niigata Cancer Center Hospital, National Cancer Center Hospital East, Saitama Cancer Center, Tokushima University, National Hospital Organization Hokkaido Medical Center, Kyushu University - Kyushu University Hospital, Kindai University, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology, National Cancer Center Hospital and Kyushu University - Kyushu University Hospital
Downloads 33 (1,277,121)

Abstract:

Loading...

Epidermal growth factor receptor (EGFR), Tyrosine kinase inhibitor, Circulating tumor DNA, chemotherapy, Osimertinib

3.

Pemetrexed Plus Platinum as Second-Line Treatment for Patients with Pleural Mesothelioma Treated with Nivolumab Plus Ipilimumab

Number of pages: 26 Posted: 08 Apr 2025
Sawana Ono, Hirokazu Taniguchi, Koji Kuroda, Teppei Hashimoto, Asuka Okada, Yasuhiro Goto, Hidenori Kitai, Yoichi Nakamura, Shinsuke Ogusu, Tetsunari Hase, Takayo Ota, Noriyuki Ebi, Makoto Furugen, Taishi Harada, Yoshiaki Kinoshita, Takaki Mizoguchi, Katsumi Nakatomi, Yoshifumi Soejima, Takahiro Yamada, Shinnosuke Takemoto and Hiroshi Mukae
affiliation not provided to SSRN, Nagasaki University, University of Occupational and Environmental Health, University of Occupational and Environmental Health, Osaka City General Hospital, Fujita Health University, Hokkaido University, affiliation not provided to SSRN, Saga University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of the Ryukyus, affiliation not provided to SSRN, Fukuoka University Chikushi Hospital, Kanazawa Medical University, National Hospital Organization Ureshino Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University and Nagasaki University - Department of Respiratory Medicine
Downloads 33 (1,277,121)

Abstract:

Loading...

Mesothelioma, Chemotherapy, Pemetrexed, Platinum, Second-line

4.

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer

Number of pages: 22 Posted: 17 Dec 2025
Kazumasa Akagi, Hirokazu Taniguchi, Minoru Fukuda, Takuya Yamazaki, Daisuke Takao, Ryuta Tagawa, Fumiko Hayashi, Ryosuke Ogata, Sawana Ono, Hiromi Tomono, Takayuki Suyama, Noritaka Honda, Yasuhiro Umeyama, Yosuke Dotsu, Midori Matsuo, Hiroshi Gyotoku, Hiroaki Senju, Shinnosuke Takemoto, Hiroshi Soda, Takashi Mizowaki, Takaya Ikeda, Seiji Nagashima, Yutaro Tasaki, Daisuke Nakamura, Kazutoshi Komiya, Katsumi Nakatomi, Eisuke Sasaki, Koichi Hirakawa, Ryo Toya, Kazuto Ashizawa and Hiroshi Mukae
National Cancer Center Research Institute, Nagasaki University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Sasebo City General Hospital, affiliation not provided to SSRN, Sasebo City General Hospital, affiliation not provided to SSRN, Nagasaki University, affiliation not provided to SSRN, Nagasaki University, Sasebo City General Hospital, Nagasaki University, Nagasaki University, Nagasaki University, Sasebo City General Hospital, Nagasaki University, Sasebo City General Hospital, Sasebo City General Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University - Nagasaki University Hospital, Nagasaki University - Nagasaki University Hospital, affiliation not provided to SSRN, National Hospital Organization Ureshino Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University - Nagasaki University Hospital, Nagasaki University - Nagasaki University Hospital and Nagasaki University - Department of Respiratory Medicine
Downloads 32 (1,290,922)

Abstract:

Loading...

Limited-stage, Small Cell Lung Cancer, Amrubicin, Cisplatin, Accelerated, Hyperfractionated, radiotherapy

5.

Evaluating the Impact of Renal Function Assessment Methods on Pemetrexed-Based Chemoimmunotherapy in Patients with Non-Small Cell Lung Cancer and Low Programmed Death-Ligand 1 Expression

Number of pages: 21 Posted: 02 Jun 2025
Naoya Nishioka, Tadaaki Yamada, Tae Hata, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Makoto Hibino, Asuka Okada, Naoya Nishimura, Takeo Ogawa, Yusuke Chihara, Hayato Kawachi, Takashi Kijima and Koichi Takayama
Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, Fujita Health University, Kurashiki Central Hospital, Hyogo Medical University, Niigata University - Medical and Dental Hospital, St. Marianna University School of Medicine, affiliation not provided to SSRN, Kansai Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University, affiliation not provided to SSRN, Shonan Kamakura General Hospital, Kurume University - Department of Internal Medicine, Saitama Medical University, affiliation not provided to SSRN, Shonan Fujisawa Tokushjukai Hospital, Osaka City General Hospital, Kyoto Prefectural University of Medicine, Kyoto Prefectural University of Medicine, affiliation not provided to SSRN, Kyoto Prefectural University of Medicine, Hyogo Medical University and Kyoto Prefectural University of Medicine
Downloads 27 (1,359,097)

Abstract:

Loading...

Non-small cell lung cancer, Chemoimmunotherapy, Pemetrexed, Creatinine clearance, Jaffe method, Enzymatic method

6.

Biological Impact of Chemotherapy During Treatment with Egfr Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer Positive for Egfr Activating Mutations

Number of pages: 22 Posted: 11 Jul 2025
Eiji Iwama, Kazuko Sakai, Taishi Harada, Shintaro Kanda, Shunichi Sugawara, Toshihide Yokoyama, Hirokazu Taniguchi, Kaoru Tanaka, Ryo Toyozawa, Kenichi Koyama, Yoshitaka Zenke, Gen Kida, Yasuhiko Nishioka, Hiroshi Yokouchi, Masayuki Hirose, Kazuto Nishio, Yuichiro Ohe, Nobuyuki Yamamoto and Isamu Okamoto
Kyushu University - Kyushu University Hospital, Kindai University - Kindai University Hospital, affiliation not provided to SSRN, Shinshu University - Department of Hematology and Medical Oncology, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kurashiki Central Hospital - Department of Respiratory Medicine, Nagasaki University, Kindai University, National Hospital Organization Kyushu Cancer Center, Niigata Cancer Center Hospital, National Cancer Center Hospital East, Saitama Cancer Center, Tokushima University, National Hospital Organization Hokkaido Medical Center, Kyushu University - Kyushu University Hospital, Kindai University, National Cancer Center Hospital, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology and Kyushu University - Kyushu University Hospital
Downloads 22 (1,424,331)

Abstract:

Loading...

Epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor, Circulating tumor DNA, chemotherapy, Osimertinib